PL1951747T3 - Sposób syntezy i związki pośrednie do syntezy kaspofunginy - Google Patents

Sposób syntezy i związki pośrednie do syntezy kaspofunginy

Info

Publication number
PL1951747T3
PL1951747T3 PL06818498T PL06818498T PL1951747T3 PL 1951747 T3 PL1951747 T3 PL 1951747T3 PL 06818498 T PL06818498 T PL 06818498T PL 06818498 T PL06818498 T PL 06818498T PL 1951747 T3 PL1951747 T3 PL 1951747T3
Authority
PL
Poland
Prior art keywords
intermediates
caspofungin
synthesis
processes
preparing
Prior art date
Application number
PL06818498T
Other languages
English (en)
Inventor
Johannes Ludescher
Ingolf Macher
Ole Storm
Stephan Bertel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of PL1951747T3 publication Critical patent/PL1951747T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL06818498T 2005-11-15 2006-11-13 Sposób syntezy i związki pośrednie do syntezy kaspofunginy PL1951747T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05024961A EP1785432A1 (en) 2005-11-15 2005-11-15 Process and intermediates for the synthesis of caspofungin.
EP06818498A EP1951747B1 (en) 2005-11-15 2006-11-13 Process and intermediates for the synthesis of caspofungin
PCT/EP2006/010867 WO2007057141A1 (en) 2005-11-15 2006-11-13 Process and intermediates for the synthesis of caspofungin

Publications (1)

Publication Number Publication Date
PL1951747T3 true PL1951747T3 (pl) 2009-12-31

Family

ID=36001076

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06818498T PL1951747T3 (pl) 2005-11-15 2006-11-13 Sposób syntezy i związki pośrednie do syntezy kaspofunginy

Country Status (17)

Country Link
US (1) US20080319162A1 (pl)
EP (2) EP1785432A1 (pl)
JP (1) JP4966314B2 (pl)
KR (1) KR101342304B1 (pl)
CN (1) CN101305018B (pl)
AT (1) ATE435233T1 (pl)
BR (1) BRPI0618591A2 (pl)
CA (1) CA2626921C (pl)
DE (1) DE602006007612D1 (pl)
DK (1) DK1951747T3 (pl)
ES (1) ES2327962T3 (pl)
HR (1) HRP20090474T1 (pl)
IL (1) IL190333A (pl)
PL (1) PL1951747T3 (pl)
PT (1) PT1951747E (pl)
SI (1) SI1951747T1 (pl)
WO (1) WO2007057141A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2049142T5 (pl) 2006-07-26 2016-09-30 Sandoz Ag Preparaty kaspofunginy
US20090291996A1 (en) * 2008-05-21 2009-11-26 Ferenc Korodi Caspofungin free of caspofungin Co
US8048853B2 (en) 2008-06-13 2011-11-01 Xellia Pharmaceuticals Aps Process for preparing pharmaceutical compound and intermediates thereof
EP2240507A2 (en) * 2008-06-25 2010-10-20 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Processes for preparing high purity aza cyclohexapeptides
CN102076707A (zh) * 2008-06-25 2011-05-25 特瓦药厂私人有限公司 无卡泊芬净杂质a的卡泊芬净
TW201024322A (en) * 2008-12-31 2010-07-01 Chunghwa Chemical Synthesis & Biotech Co Ltd Preparation method for nitrogen containing heterocyclic hexapeptide with high conversion rate
WO2010108637A1 (en) 2009-03-27 2010-09-30 Axellia Pharmaceuticals Aps Crystalline compound
US20120190815A1 (en) * 2009-08-06 2012-07-26 Tianhui Xu Azacyclohexapeptide or its pharmaceutical acceptable salt, preparing method and use thereof
WO2012041801A1 (en) * 2010-09-28 2012-04-05 Dsm Sinochem Pharmaceuticals Netherlands B.V. Method for isolating a cyclohexapeptide
CN102367267B (zh) 2010-11-10 2013-09-04 上海天伟生物制药有限公司 一种卡泊芬净的制备方法
CN102367268B (zh) 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其用途
CN102367269B (zh) 2010-11-10 2013-11-06 上海天伟生物制药有限公司 一种卡泊芬净类似物及其制备方法和用途
KR101331984B1 (ko) 2010-12-09 2013-11-25 종근당바이오 주식회사 카스포펀진 제조방법 및 그의 신규 중간체
CN102219833A (zh) * 2011-04-18 2011-10-19 深圳市健元医药科技有限公司 一种更加安全的棘白菌类抗真菌药的制备方法
CN102746384B (zh) 2011-04-22 2016-01-20 上海天伟生物制药有限公司 一种高纯度的卡泊芬净或其盐及其制备方法和用途
EP2703409B1 (en) 2011-04-28 2017-01-18 Unitris Biopharma Co., Ltd Intermediate for synthesizing caspofungin and preparation method therefor
CN106478781B (zh) * 2015-09-02 2020-04-07 正大天晴药业集团股份有限公司 卡泊芬净的制备方法
CN105440109B (zh) * 2015-11-26 2019-03-05 成都摩尔生物医药有限公司 一种卡泊芬净的制备方法
CN109721641B (zh) * 2017-10-31 2021-08-03 鲁南制药集团股份有限公司 一种卡泊芬净的合成方法
EP3620462A1 (en) * 2018-09-04 2020-03-11 Xellia Pharmaceuticals ApS Process for the preparation of caspofungin

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202309A (en) 1989-06-30 1993-04-13 Merck & Co., Inc. Antibiotic cyclopeptide fermentation product
US5194377A (en) 1989-06-30 1993-03-16 Merck & Co., Inc. Antibiotic agent
US6030944A (en) 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
WO1994009033A1 (en) * 1992-10-16 1994-04-28 Merck & Co., Inc. An improved process for cyclohexapeptidyl bisamine compounds
US5378804A (en) 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
WO1996006109A1 (en) * 1994-08-23 1996-02-29 Merck & Co., Inc. An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides
US5552521A (en) 1995-02-10 1996-09-03 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
HRP970318B1 (en) 1996-06-14 2002-06-30 Merck & Co Inc A process for preparing certain aza cyclohexapeptides
US5936062A (en) 1997-06-12 1999-08-10 Merck & Co., Inc. Process for preparing certain aza cyclohexapeptides
US5965612A (en) * 1997-08-22 1999-10-12 Merck & Co., Inc. 4-cyano-4-deformylsordaricin derivatives
US5972996A (en) * 1997-08-22 1999-10-26 Merck & Co., Inc. 4-cyano-4-deformylsordarin derivatives
EP1351701A2 (en) * 2001-01-09 2003-10-15 Merck & Co., Inc. Active metabolite of antifungal compound
AR035808A1 (es) 2001-04-12 2004-07-14 Merck & Co Inc Proceso de deshidratacion capaz de minimizar la epimerizacion de un grupo hidroxilo por ciertas equinocandinas

Also Published As

Publication number Publication date
KR101342304B1 (ko) 2013-12-16
EP1785432A1 (en) 2007-05-16
HRP20090474T1 (en) 2009-10-31
EP1951747A1 (en) 2008-08-06
IL190333A (en) 2010-12-30
ES2327962T3 (es) 2009-11-05
US20080319162A1 (en) 2008-12-25
BRPI0618591A2 (pt) 2011-09-06
CA2626921C (en) 2013-09-17
JP4966314B2 (ja) 2012-07-04
DE602006007612D1 (de) 2009-08-13
SI1951747T1 (sl) 2009-12-31
WO2007057141A1 (en) 2007-05-24
PT1951747E (pt) 2009-08-12
CA2626921A1 (en) 2007-05-24
DK1951747T3 (da) 2009-10-12
JP2009515917A (ja) 2009-04-16
CN101305018A (zh) 2008-11-12
CN101305018B (zh) 2013-03-27
ATE435233T1 (de) 2009-07-15
KR20080069998A (ko) 2008-07-29
EP1951747B1 (en) 2009-07-01

Similar Documents

Publication Publication Date Title
IL190333A (en) Process and intermediates for the synthesis of caspofungin
UA101060C2 (ru) Способ получения соединения n-[транс-4-[4-(циклопропилметил)-1-пиперазинил]циклогексил]-4-[[(7r)-7-этил-5,6,7,8-тетрагидро-5-метил-8-(1-метилетил)-6-оксо-2-птеридинил]амино]-3-метоксибензамида
GB0305704D0 (en) Radiofluorination methods
MY149070A (en) 1h-quinazoline-2,4-diones
MY147633A (en) Preparation of azoxystrobin
ZA200702700B (en) Diagnostic compounds
TW200616995A (en) Novel compounds
TW200618796A (en) Ammonolysis process for the preparation of intermediates for DPP IV inhibitors
PL1758852T3 (pl) Podstawione związki cyklopentenu
TW200716529A (en) New compounds II
TW200640914A (en) Novel processes for the preparation of a benzofuran
TW200728310A (en) Process for the preparation of ferri-succinylcasein
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
TNSN06260A1 (en) Process for the preparation of tryptase inhibitors
TW200719889A (en) Amino acid derivatives
TW200722418A (en) Novel compounds
PL1912954T3 (pl) Nowe inhibitory proteaz cysteinowych i ich terapeutyczne zastosowania
UA94604C2 (en) Neuroprotective compounds and uses thereof
DE602004031129D1 (de) Verfahren zur herstellung von quetiapin
MXPA05013649A (es) Fluorbutenos nematicidas que contienen tiazolina.
WO2004096828A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes
SG155231A1 (en) Process for synthesis of dialkoxyorganoboranes
MXPA05007696A (es) Modificacion cristalina de un complejo de manganeso.
MX2007012472A (es) (+)-y-(-)-8-alquil-3-(trifluoralquilsulfoniloxi)-8-azabicicl (3.2.1)cot-2-eno.
TW200716530A (en) New compounds I